Reconsideration of Insulin Signals Induced by Improved Laboratory Animal Diets, Japanese and American Diets, in IRS-2 Deficient Mice

Experimental and Clinical Endocrinology and Diabetes

Volumn 117, Issue 10, 2009, Pages 577-586

  Hashimoto, H ^a   Arai, T ^b   Mori, A ^b   Kawai, K ^a   Hikishima, K ^a,e   Ohnishi, Y ^a   Eto, T ^a   Ito, M ^a   Hioki, K ^a   Suzuki, R ^c   Ohsugi, M ^c   Saito, M ^a   Ueyama, Y ^d   Okano, H ^e   Yamauchi, T ^c   Kubota, N ^c   Ueki, K ^c   Tobe, K ^c   Tamaoki, N ^a   Kadowaki, T ^c   Kosaka, K ^a,c   more..

^a CENTRAL INSTITUTE FOR EXPERIMENTAL ANIMALS   (Japan)

^b NIPPON VETERINARY AND LIFE SCIENCE UNIVERSITY   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

^d TOKAI UNIVERSITY   (Japan)

^e KEIO UNIVERSITY   (Japan)

Author keywords

Adipocytokines; Autoimmunity; Diabetes; Fatty acid synthesis; Metabolic features; Obesity

Indexed keywords

ADIPOCYTOKINE; CHOLESTEROL; GLUCOSE; INSULIN; INSULIN RECEPTOR SUBSTRATE 2; RESISTIN; RNA; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA;

ADIPOCYTE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIET; DISEASE EXACERBATION; ENZYME ACTIVITY; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE TEST; IMPAIRED GLUCOSE TOLERANCE; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INSULIN TOLERANCE TEST; LIPID STORAGE; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; NUTRIENT CONTENT; PERITONEAL CAVITY; PRIORITY JOURNAL; RNA ANALYSIS; SIGNAL TRANSDUCTION; SKELETAL MUSCLE; TRIACYLGLYCEROL BLOOD LEVEL; WHITE ADIPOSE TISSUE;

ADIPONECTIN; ADIPOSE TISSUE, WHITE; ANIMALS; BLOOD GLUCOSE; BODY WEIGHT; DIABETES MELLITUS, EXPERIMENTAL; DIET; DIETARY FATS; ENZYME-LINKED IMMUNOSORBENT ASSAY; GLUCOSE TOLERANCE TEST; INSULIN; INSULIN RECEPTOR SUBSTRATE PROTEINS; INSULIN RESISTANCE; LIVER; MAGNETIC RESONANCE IMAGING; MICE; MUSCLE, SKELETAL; PANCREAS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 70450228532     PISSN: 09477349     EISSN: 14393646     Source Type: Journal    
DOI: 10.1055/s-0029-1225352     Document Type: Article

References (37)

1. Arai T, Machida Y, Sasaki M et al. Hepatic enzyme activities and plasma insulin concentrations in diabetic voles. Vet Res Commun 1989; 13: 421-426
2. Arai T, Hashimoto H, Kawai K et al. Fulminant type 1 diabetes mellitus observed in insulin receptor substrate 2 deficient mice. Clin Exp Med 2008; 8: 93-99 (Pubitemid 351999728)
3. Elias D, Markovits D, Reshef T et al. Induction and therapy of autoimmune diabetes in the non-obese diabetic (NOD/Lt) mouse by a 65-kDa heat shock protein. Proc Natl Acad Sci USA. 1990; 87: 1576-1580 (Pubitemid 20080351)
4. Halestrap AP, Denton RM. Insulin and the regulation of adipose tissue acetyl-coenzyme A caroboxylase. Biochem J. 1973; 132: 509-517
5. Hashimoto H, Arai T, Takeguchi A et al. Ontogenetic characteristics of enzyme activities and plasma metabolites in C57BL/6J:Jcl mice deficient in insulin receptor substrate 2. Comp Med 2006; 56: 176-187 (Pubitemid 43877986)
6. Hess B, Wieker HJ. Pyruvate kinase from yeast. In: Bergmeyer HU, Ed. Methods of Enzymatic Analysis, vol.2. New York, Academic Press; 1974, 778-783
7. Hotamisligil CS. The role of TNFalpha and TNF receptors in obesity and insulin resistance. J Intern Med 1999; 245: 621-625 (Pubitemid 29278870)
8. Huggett AC, Nixon DA. Use of glucose oxidase, peroxidase and o-dianisidine in determination of blood and urinary glucose. Lancet 1957; 2: 368-370
9. Inoue M, Ohtake T, Motomura W et al. Increased expression of PPARgamma in high fat diet-induced liver steatosis in mice. Biochem Biophys Res Commun 2005; 336, pp215-222 all
10. Jiang T, Wang Z, Proctor C. Diet-induced obesity in C57BL/6J mice causes increased renal lipid accumulation and glomerulosclerosis via a sterol regulatory element-binding protein-lc-dependent pathway. J Biol Chem 2005; 280: 32317-32325
11. Kadowaki T. Insights into insulin resistance and type 2 diabetes from knockout mouse models. J Clin Invest 2000; 106: 459-465 (Pubitemid 30666378)
12. Kahn BB, Flier JS. Obesity and insulin resistance. J Clin Invest 2000; 106: 473-481
13. Kamei N, Tobe K, Suzuki R et al. Overexpression of monocyte chemoattractant protein-1 in adipose tissues causes macrophage recruitment and insulin resistance. J Biol Chem 2006; 281: 26602-26614 (Pubitemid 44401869)
14. Kubota N, Tobe K, Terauchi Y et al. Disruption of insulin receptor substrate 2 causes type 2 diabetes because of liver insulin resistance and lack of compensatory beta-cell hyperplasia. Diabetes 2000; 49:1880-1889 (Pubitemid 30812921)
15. Margalit M, Shalev Z, Pappo O et al. Glucocerebroside ameliorates the metabolic syndrome in OB/OB mice. J Pharmacol Exp Ther 2006; 319: 105-110 (Pubitemid 44455114)
16. Martin BB, Denton RM. The intracellular localization of enzymes in white-adipose-tissue fat-cells and permeability properties of fat-cell mitochondria. BiochemJ 1970; 117: 861-877
17. Okumura T, Kahgo Y. Increased expression of PPargamma in fatty liver induced by high fat diet. Nippon Rinsho 2006; 64: 1056-1061
18. Rej R, Horder M. Aspartate aminotransferase (glutamate oxaloacetate transaminase). In: Bergmeyer HU, Ed. Methods of Enzymatic Analysis, third edition. Verlag Chemie, New York; 1983; pp 416-433
19. Rassmeisl M, Rim JS, Koza RA et al. Variation in type 2 diabetes - related traits in mouse strains susceptible to diet-induced obesity. Diabetes 2003; 52:1958-1966
20. Schadinger SE, Bucher NL, Schreiber BM et al. PPARgamma2 regulates lipogenesis and lipid accumulation in steatotic hepatocytes. J Physiol Endocrinol Metab 2005; 288: E1195-E1205
21. Schroeder-Glaeckler JM, Rahman SM Janssen RC et al. CCAAT/enhancerbinding protein beta deletion reduces adiposity, hepatic steatosis, and diabetes in Lepr (db/db) mice. J Biol Chem 2007; 282: 15717-15729
22. Sesti G, Federici M, Hribal ML et al. Defects of the insulin receptor substrate (IRS) system in human metabolic disorders. FASEB J 2001 ; 15: 2099-2111 (Pubitemid 32927927)
23. Shimomura I, Bashmakov Y, Horton JD. Increased levels of nuclear SREBP-Ic associated with fatty livers in two mouse models of diabetes mellitus. J Biol Chem 1999; 274, pp30028-30032
24. Shimomura I, Hammer RE, lkemoto S et al. Leptin reverses insulin resistance and diabetes mellitus in mice with congenital lipodystrophy. Nature 1999; 401: 73-76
25. Shiota M, Pastic C, Fujimoto Y et al. Glucokinase gene locus transgenic mice are resistant to the development of obesity-induced type 2 diabetes. Diabetes 2001; 50: 622-629
26. Shulman CI. Cellular mechanisms of insulin resistance. J Clin Invest 2000; 106: 171-176
27. Steppan CM, Bailey ST, BhatSetal.The hormone resistin links obesity to diabetes. Nature 2001; 409: 307-312
28. Suzuki R, Tobe K, Aoyama M et al. Both insulin signaling defects in the liver and obesity contribute to insulin resistance and cause diabetes in Irs2-/- mice. J Biol Chem 2004; 279: 25039-25049 (Pubitemid 38756752)
29. Takahashi M, lkemoto S, Ezaki O. Effect of the Fat/Carbohydrate ratio in the diet on obesity and oral glucose tolerance in C57BL/6J mice. J Nutr Sci Vitaminol 1999; 45: 583-593 (Pubitemid 30002813)
30. Takeda Y, Suzuki F, Inoue H. ATP citrate lyase (Citrate cleavage enzyme). In: Lowenstein JM, Ed. Methods in Enzymology 1969; vol.13. Academic Press, New York, pp.153-160
31. Terauchi Y, Iwamota K, Tamemoto H et al. Development of non-insulindependent diabetes mellitus in the double knockout mice with disruption of insulin receptor substrate-1 and beta cell glucokinase genes. Genetic reconstitution of diabetes as a polygenic disease. J Clin Invest 1997; 99: 861-866
32. Tobe K, Suzuki R, Aoyama M et al. Increased expression of the sterol regulatory element-binding protein-1 gene in insulin receptor substrate2(-/-) mouse liver. J Biol Chem 2001; 19: 38337-38340
33. Tsuji A, Torres-Rosado A, Aral T et al. Hepsin, a cell membrane-associated protease. Characterization, tissue distribution and gene localization. J Biol Chem 266, 1991; 16948-16953
34. Vinuela E, Salas M, Sols A. Glucokinase and hexokinase in liver in relation to glycogen synthesis. J Biol Chem 1963; 238: PC1175-PC1177
35. Wang YX, Lee CH, Tiep S et al. Peroxisome-proliferator-activated receptor delta activates fat metabolism to prevent obesity. Cell 2003; 113, pp159-170 (Pubitemid 36514968)
36. Wang Z, Jiang T, Li J et al. Regulation of renal lipid metabolism, lipid accumulation, and glomerulosclerosis in FVBdb/db mice with type 2 diabetes. Diabetes 2005; 54, pp2328-2335
37. Zimmet P, Alberti K, Shaw J. Global and societal implications of the diabetes epidemic. Nature 2001; 414: 782-787 (Pubitemid 34000780)